TransMedics Group, Inc. (TMDX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about TransMedics Group, Inc. (TMDX)
Go deeper and ask any question about TMDX
Company Performance
Current Price
as of Sep 13, 2024$151.42
P/E Ratio
4241.46
Market Cap
$5.05B
Description
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Metrics
Overview
- HQAndover, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerTMDX
- Price$151.42+1.53%
Trading Information
- Market Cap$5.05B
- Float96.60%
- Average Daily Volume (1m)806,708
- Average Daily Volume (3m)793,812
- EPS$0.08
Company
- Revenue$358.76M
- Rev Growth (1yr)117.87%
- Net Income$12.19M
- Gross Margin60.51%
- EBITDA Margin14.97%
- EBITDA$17.11M
- EV$5.47B
- EV/Revenue15.24
- P/E4,241.46
- P/S14.89
Documents
SEC Filings
Earnings Calls
Factset Street Account